Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
US6194001A · kind A · utility
11Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 1999 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Jun 23, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are tablet formulations in one embodiment comprising clavulanic acid or salt thereof, amoxycillin, and trehalose. The trehalose is, for example, amorphous anhydrous trehalose. The amorphous anhydrous trehalose is present in an amount, for example, of 5 to 50%. The formulation may further comprise, for example, desiccants, such as silica gel, or lubricants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.